ARCHIVES

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 13 No. 38 | October 2, 1987

Download PDF Visit The Full Archive

Related Articles

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Bristol-Myers Nominations Open

August 10, 1979

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006